|
(2R,3S,4S)-leucodelphinidin |
|
CHEBI:6417 |
|
(2R,3S,4S)-leucodelphinidin |
|
A flavan-3,3',4,4',5,5',7-heptol that has (2R,3S,4S) configuration. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C15H14O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,13-22H/t13-,14-,15+/m0/s1 |
ZEACOKJOQLAYTD-SOUVJXGZSA-N |
O[C@H]1[C@@H](O)c2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1 |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
Outgoing
|
(2R,3S,4S)-leucodelphinidin
(CHEBI:6417)
has functional parent
(+)-gallocatechin
(CHEBI:31018)
(2R,3S,4S)-leucodelphinidin
(CHEBI:6417)
has role
metabolite
(CHEBI:25212)
(2R,3S,4S)-leucodelphinidin
(CHEBI:6417)
is a
(2R,3S,4S)-leucoanthocyanidin
(CHEBI:138176)
(2R,3S,4S)-leucodelphinidin
(CHEBI:6417)
is a
flavan-3,3',4,4',5,5',7-heptol
(CHEBI:71216)
(2R,3S,4S)-leucodelphinidin
(CHEBI:6417)
is a
leucoanthocyanidin
(CHEBI:60835)
|
|
(2R,3S,4S)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,4,5,7-tetrol
|
(2R,3S)-gallocatechin-4β-ol
|
ChEBI
|
(2R,3S,4S)-2-(3,4,5-trihydroxyphenyl)chroman-3,4,5,7-tetrol
|
ChEBI
|
(2R,3S,4S)-3,3',4,4',5,5',7-heptahydroxyflavan
|
ChEBI
|
(2R,3S,4S)-3,4,5,7,3',4',5'-heptahydroxyflavan
|
ChEBI
|
Leucodelphinidin
|
KEGG COMPOUND
|
16664326
|
PubMed citation
|
Europe PMC
|
3293532
|
PubMed citation
|
Europe PMC
|
7814088
|
PubMed citation
|
Europe PMC
|
|